Perrigo
Dublin
About Perrigo
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. It has a presence in multiple countries and serves customers around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $4.6B
- Funding stage: M&A
- Last round: Post-IPO Debt (Sep 2024)
- Ticker: nyse:PRGO
- Website: perrigo.com
- Phone: (269)673-8451
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/perrigo-10726 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.